Zobrazeno 1 - 2
of 2
pro vyhledávání: '"59"'
Autor:
Emilio Porfiri, Isabella Wheeley, Mehran Afshar, Manuela Miscoria, Sarah Pirrie, Antonio D Bardoli, Clive Stubbs
Publikováno v:
Anticancer Research. 37:253-260
BACKGROUND Sunitinib is a tyrosine kinase inhibitor (TKI) targeting tumour angiogenesis in patients with advanced renal cell carcinoma (RCC). Currently no universally agreed model exists correlating the expression of angiogenesis markers with the suc
Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients
Autor:
Akira Takeuchi, Takamitsu Asano, Ken Maeno, Satoshi Fukuda, Yoshitsugu Inoue, Masaya Takemura, Kazuki Sone, Akio Niimi, Tetsuya Oguri, Yutaka Ito, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Yuki Kitamura, Keima Ito, Osamu Takakuwa
Publikováno v:
Anticancer Research. 37
BACKGROUND/AIM The aim of the present study was to determine the clinical value of tumor marker levels for previously treated NSCLC patients. PATIENTS AND METHODS We retrospectively screened 113 previously treated patients with advanced NSCLC who wer